MP Manns, P Burra, J Sargent, R Horton, TH Karlsen - The Lancet, 2018 - thelancet.com
Comment 622 www. thelancet. com Vol 392 August 25, 2018 populations. 1, 17 Viral
hepatitis B and D will, however, remain major challenges in terms of drug development and …